Melanotan I (afamelanotide) clinical trials: 13 trials
Page 1 of 1
Read 13 Melanotan I (afamelanotide) clinical trials with posted results or linked papers with results in PepBank.
- Multicentre Phase III Erythropoietic Protoporphyria Study
NCT04053270 · Phase 3 · Completed
Posted results
- Phase III Confirmatory Study in Erythropoietic Protoporphyria
NCT01605136 · Phase 3 · Completed
Posted results
- Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)
NCT00979745 · Phase 3 · Completed
Posted results
- Afamelanotide in Patients Suffering From Polymorphic Light Eruption (PLE)
NCT04704713 · Phase 3 · Completed
Posted results
- A Safety Extension Study in Patients With Erythropoietic Protoporphyria (EPP)
NCT04578496 · Phase 3 · Completed
Posted results
- Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)
NCT01097044 · Phase 2 · Completed
Posted results
- Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients
NCT06388642 · Phase 1/2 · Completed
Posted results
- Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV)
NCT04525157 · Phase 2 · Completed
Posted results
- Afamelanotide as Adjunctive Therapy in Patients Undergoing Photodynamic Therapy (PDT) Utilising Porfimer Sodium
NCT04425746 · Phase 2 · Completed
Posted results
- Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Variegate Porphyria (VP)
NCT05854784 · Phase 2 · Completed
Posted results
- A Proof of Concept Study to Evaluate the Safety of Afamelanotide in Patients With Acute Arterial Ischaemic Stroke (AIS)
NCT04962503 · Phase 2 · Completed
Posted results
- Afamelanotide in Patients Suffering With Acne Vulgaris
NCT04943159 · Phase 2 · Completed
Posted results
- Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV)
NCT01430195 · Phase 1 · Completed
Linked paper with results